跳至主要内容
临床试验/ISRCTN14037053
ISRCTN14037053进行中(未招募)1 期

Adaptive phase I clinical trial of a preventive vaccine consisting of autologous dendritic cells previously incubated with S-protein from SARS-CoV-2, in subjects negative for COVID-19 infection and anti-SARS-CoV-2 antibodies

Ministry of Health0 个研究点目标入组 27 人开始时间: 2020年12月31日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
27

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. 18 years or older
  • 2. In relatively good health with adequate physical and mental function
  • 3. Increased risk for medical complications associated with COVID-19 infection or increased risk for exposure to SARS-CoV-2

排除标准

  • 1. Active COVID-19 infection by PCR testing
  • 2. Pre-existing IgG or IgM SARS-CoV-2 antibodies
  • 3. Pregnant, Known hypersensitivity to GM-CSF
  • 4. Known active immune deficiency disease or active HIV
  • 5. HBV, HCV, On active treatment with corticosteroids or other immunosuppressive agent
  • 6. Participated in previous COVID-19 vaccine study

研究者

相似试验

已完成
1 期
A phase I/II clinical trial of prophylactic extended-field radiotherapy of pelvic and para-aortic lymph nodes in locally advanced squamous cell carcinoma of the uterine cervix using carbon-ion beamsuterine cervical cancer
JPRN-UMIN000016169ational Institute of Radiological Sciences20
招募中
2 期
High humidity decreases symptomatic patent ductus arteriosus
JPRN-jRCT1032190068Hirata Michisato30
已完成
1 期
A phase I clinical trial of prophylactic extended-field radiotherapy of pelvic and para-aortic lymph nodes using carbon-ion beams and concurrent cisplatin chemotherapy for locally advanced squamous cell carcinoma of the uterine cervixterine cervical cancer
JPRN-UMIN000008349ational Institute of Radiological Sciences12
尚未招募
1 期
MAMBISA StudyCOVID-19SARS-CoV2Disease PreventionCoronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirus
RPCEC00000345Center for Genetic Engineering and Biotechnology (CIGB), in Havana88
进行中(未招募)
1 期
Phase I/IIa clinical trial on the safety and preliminary efficacy of donor-derived anti-leukemia cytotoxic T lymphocytes for the prevention of leukemia relapse in children given haploidentical hematopoietic stem cell transplantatioeukemia relapse prevention given haploidentical hematopoietic stem cell transplantationMedDRA version: 21.1Level: PTClassification code 10000880Term: Acute myeloid leukaemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10000844Term: Acute lymphoblastic leukaemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2019-003362-41-ITFONDAZIONE I.R.C.C.S. POLICLINICO SAN MATTEO15
Dendritic cell vaccine to prevent COVID-19 | 临床试验